← Back to Search

Monitoring Device for Head and Neck Cancers

N/A
Waitlist Available
Led By Voichita Bar-Ad, MD
Research Sponsored by Sidney Kimmel Cancer Center at Thomas Jefferson University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 3 months
Awards & highlights

Study Summary

This trial uses a Fitbit to monitor activity and sleep data to see if it can help detect early signs of disease or treatment-related symptoms in people with head and neck cancer.

Eligible Conditions
  • Head and Neck Cancers

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of time patients wear the Fitbit Charge 3 device (compliance)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Device Feasibility (Fitbit Charge 3)Experimental Treatment1 Intervention
Participants wear the Fitbit Charge 3 device from the time of CT simulation for RT planning throughout the entire RT course.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Monitoring Device
2018
Completed Phase 2
~2380

Find a Location

Who is running the clinical trial?

Sidney Kimmel Cancer Center at Thomas Jefferson UniversityLead Sponsor
162 Previous Clinical Trials
10,870 Total Patients Enrolled
Voichita Bar-Ad, MDPrincipal InvestigatorSidney Kimmel Cancer Center at Thomas Jefferson University
3 Previous Clinical Trials
151 Total Patients Enrolled

Frequently Asked Questions

~6 spots leftby Apr 2025